Technical Analysis for VRDN - Viridian Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 14.25 | -0.35% | -0.05 |
VRDN closed down 0.35 percent on Tuesday, April 23, 2024, on 58 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 7
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New Downtrend | Bearish | 0.00% | |
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Lower Bollinger Band Walk | Weakness | -0.35% | |
| Lower Bollinger Band Touch | Weakness | -0.35% | |
| Oversold Stochastic | Weakness | -0.35% | |
| Expansion Breakdown | Bearish Swing Setup | -2.40% | |
| Stochastic Buy Signal | Bullish | -2.40% | |
| Lower Bollinger Band Touch | Weakness | -2.40% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 14 hours ago |
| Rose Above Previous Day's High | about 20 hours ago |
| Up 3% | about 20 hours ago |
| Up 2% | about 20 hours ago |
| Up 1% | about 20 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2024
Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian’s most advanced program, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED). Viridian is headquartered in Boulder, Colorado, with research and development operations in Waltham, Massachusetts.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Biology Monoclonal Antibody Thyroid Eye Disease
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Biology Monoclonal Antibody Thyroid Eye Disease
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 28.99 |
| 52 Week Low | 10.925 |
| Average Volume | 921,600 |
| 200-Day Moving Average | 17.76 |
| 50-Day Moving Average | 17.55 |
| 20-Day Moving Average | 16.07 |
| 10-Day Moving Average | 15.23 |
| Average True Range | 0.87 |
| RSI (14) | 27.54 |
| ADX | 25.27 |
| +DI | 14.26 |
| -DI | 27.89 |
| Chandelier Exit (Long, 3 ATRs) | 16.32 |
| Chandelier Exit (Short, 3 ATRs) | 16.62 |
| Upper Bollinger Bands | 18.10 |
| Lower Bollinger Band | 14.03 |
| Percent B (%b) | 0.05 |
| BandWidth | 25.33 |
| MACD Line | -0.91 |
| MACD Signal Line | -0.76 |
| MACD Histogram | -0.1467 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 15.42 | ||||
| Resistance 3 (R3) | 15.54 | 15.28 | 15.23 | ||
| Resistance 2 (R2) | 15.28 | 14.98 | 15.22 | 15.16 | |
| Resistance 1 (R1) | 14.76 | 14.79 | 14.63 | 14.64 | 15.09 |
| Pivot Point | 14.50 | 14.50 | 14.43 | 14.44 | 14.50 |
| Support 1 (S1) | 13.98 | 14.20 | 13.85 | 13.86 | 13.41 |
| Support 2 (S2) | 13.72 | 14.01 | 13.66 | 13.34 | |
| Support 3 (S3) | 13.20 | 13.72 | 13.28 | ||
| Support 4 (S4) | 13.08 |
